Maximilian Felix Blank
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (4)
Year:
2026
SnoRNAs are highly expressed in AML and play a role in leukemogenesis and leukemic maintenance. SnoRNAs can be further processed into snoRNA-derived RNAs (sdRNAs). Expression and implications of sdRNAs in AML and healthy hematopoiesis, however, remain largely elusive. We characterized sdRNA and snoRNA levels in hematopoietic stem cells (HSCs), healthy peripheral blood cells, and 159 AML patient samples at initial diagnosis. HSCs, healthy WBCs and AML blasts could be differentiated by their sdRNA expression pattern in a cell-type specific manner. In AML, high sd3’-RNA/snoRNA-hostgene ratios were associated with inverse patient outcome. Particularly, in NPM1-mutated patients with favorable risk stratification and good initial therapy response, high sd3’-RNA ratios identified a subgroup with inferior outcome, and could therefore represent biomarkers to identify those at-risk patients. High sd3’-RNA ratios were associated with clear alterations in oncogenic, inflammatory and immune response signalling. Forced expression of single sdRNAs, such as sd3’-SNORD78 and sd5’-SNORD93, enhanced clonogenic potential in AML. Total proteome and transcriptome analyses suggested NUDT21, a reported tumor suppressor with implications in inflammatory and immune response signalling, as novel target of sd3’-SNORD78. Our data introduces sdRNAs as effector molecules in healthy hematopoiesis and AML with mechanistic, diagnostic, as well as potential prognostic and therapeutic implications.
Year:
2026
RNA constitutes a large fraction of chromatin. Spatial distribution and functional relevance of RNA associating with chromatin remain largely elusive. We established a landscape analysis of RNA-chromatin interactions in human acute myeloid leukemia (AML). In total more than 50 million interactions were captured in an AML cell line. Protein-coding mRNAs and long non-coding RNAs (lncRNAs) exhibited a substantial number of cis -interactions with chromatin suggesting transcriptional activity. In contrast, small nucleolar RNAs (snoRNAs) and small nuclear RNAs (snRNAs) associated with chromatin predominantly in trans indicating chromatin specific functions. Of note, snoRNA-chromatin interaction associates with chromatin modification and is independent of the classical snoRNA-RNP complexes. Two non-canonical C/D box snoRNAs, namely SNORD118 and SNORD3A , displayed high frequency of trans -association with chromatin. The transcription of SNORD118 and SNORD3A was increased upon leukemia transformation and enriched in leukemia stem cells, but decreased during myeloid differentiation. Suppression of SNORD118 and SNORD3A impaired leukemia cell proliferation and colony forming capacity in AML cells, but had minimal impact on healthy CD34+ hematopoietic stem and progenitor cells (HSPCs). These findings highlight the functional importance of chromatin-associated RNAs overall and in particular of SNORD118 and SNORD3A in maintaining leukemia propagation.
Year:
2024
The expansion of acute myeloid leukemia (AML) blasts not only suppresses normal hematopoiesis, but also alters the microenvironment. The interplay of different components of the bone marrow gives rise to altered metabolic states and activates signaling pathways which lead to resistance and impede effective therapy. Therefore, the underlying processes and mechanisms represent attractive therapeutic leverage points for overcoming therapy resistance in AML. Here, we briefly discuss resistance mechanisms based on cell interactions and secreted soluble factors in the hematopoietic niche and provide an overview of niche‐related therapeutic targets currently undergoing preclinical and clinical investigation which may help improve the outcome in AML therapy.
Year:
2023
Collaborators (3)
Anthony D. Ho
Chair and Professor
Ruprecht Karls Universität Heidelberg
Jeroen Krijgsveld
Deutsches Krebsforschungszentrum
Fengbiao Zhou
Group leader
Heidelberg University
Make your next move.
Prepare your application
Review drafts before you send them.